Born in New York, Dr. Neil Devejian received his bachelor’s degree from the State University of New York at Binghamton in 1988 and his medical degree from the State University of New York, Upstate Medical University in Syracuse in 1992.
He completed his general surgical residency at the State University of New York, Upstate Medical University in Syracuse in1997 and his cardiac surgical training at the University of Michigan in 1999. Following this he became the John Alexander Fellow in congenital cardiac surgery under the mentorship of Dr. Edward Bove at the prestigious Mott Children’s Hospital of the University of Michigan.
As the region's only pediatric cardiac surgeon since 2001, Dr. Neil Devejian has performed more than 2,000 operations to correct congenital heart defects. He ranks as one of New York's top surgeons with the lowest mortality rate for surgery performed on infants and children with congenital heart disease. As director of the Congenital Heart Program at Albany Med, he also performs cardiac surgery for congenital conditions affecting adults and consults with pregnant women whose infants will need cardiac surgery.
Albany Med has a long tradition of providing excellent cardiac care to children. For two decades, the hospital has maintained a specialized and comprehensive program focused on the needs of patients with congenital heart disease (CHD).
At Albany Med, medical and surgical care of the highest quality is provided to patients with CHD from the Capital District and beyond.
Albany Med submits all outcomes data to the Society for Thoracic Surgeons (STS) , which maintains the most comprehensive cardiac surgical database, nationally and internationally, as well as to the New York State Department of Health; (latest year for which information is available). Both release their reports to the public.
We encourage you to visit their websites to learn about the valuable and high-quality resources available to children and adults - right here in our region - at Albany Med.
We are delighted to highlight some of the pertinent data about outcomes at Albany Med from STS's 2014-2017 full report, the most recent available.
Albany Med: 5/308 = 1.6%
Albany Med risk-adjusted overall mortality = 2.1% (top 10th percentile of all programs reporting to the STS national database).
(STAT mortality level categories allow outcomes to be assessed in relation to the complexity of the operations being performed using a multi-institutional validated complexity stratification tool. STAT mortality levels range 1-5, 5 being cases of the highest complexity).